title: The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol.
abstract: BACKGROUND
  Adverse drug events are unintended and harmful events related to medication use. They are a leading cause of visits to the emergency department, unplanned admissions to hospital and death. Adverse drug events can be misdiagnosed in the emergency department, resulting in treatment delays. Our objective was to describe a process to evaluate the effect of pharmacist-led medication review in high-risk patients in the emergency department on the number of days these patients subsequently spent in hospital within 30 days of their index visit.
  
  
  METHODS
  We describe the evaluation of a prospective multicentre quality improvement program. During the evaluation period, triage nurses will flag incoming patients to the emergency department at high risk for adverse drug events by applying a clinical decision rule consisting of 4 variables (comorbid conditions, antibiotic use within 7 days, medication changes within 28 days and age). Consecutive eligible patients will be enrolled in the study and systematically allocated to either a pharmacist-led medication review group or a control group. In the intervention group, pharmacists will collect best-possible medication histories, review the patient's medications for appropriateness and adverse drug events, and communicate the results of their medication review to patients, caregivers and physicians. In the control group, nurses will start medication reconciliation by collecting best-possible medication histories, and physicians will refer patients to onsite pharmacists for specific medication management questions as needed. Health outcomes will be assessed using anonymized data linkage to administrative health databases. The primary outcome will be the percent days spent in hospital over a 30-day period.
  
  
  CONCLUSIONS
  This protocol describes the methods for evaluating the effect of pharmacist-led medication review in high-risk patients in the emergency department on use of health services, and highlights the methodological challenges that will be encountered. We plan to disseminate the results of this evaluation through articles published in peer-reviewed journals, presentations at scientific meetings and briefing notes to institutional, provincial and national stakeholders.
authors.affiliation: Department of Emergency Medicine, University of British Columbia, Vancouver General Hospital, Vancouver, BC ; Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC.
authors.forename: Corinne M
authors.initials: CM
authors.lastname: Hohl
authors.affiliation: School of Population and Public Health, University of British Columbia, Vancouver, BC ; Centre for Health Services and Policy Research, University of British Columbia, Vancouver BC.
authors.forename: Kimberlyn
authors.initials: K
authors.lastname: McGrail
authors.affiliation: Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC ; School of Population and Public Health, University of British Columbia, Vancouver, BC.
authors.forename: Boris
authors.initials: B
authors.lastname: Sobolev
references.citation: JAMA. 2003 Mar 5;289(9):1107-16
references.pmid: 12622580
references.citation: Cochrane Database Syst Rev. 2013 Feb 28;(2):CD008986
references.pmid: 23450593
references.citation: Arch Intern Med. 2009 May 11;169(9):894-900
references.pmid: 19433702
references.citation: CMAJ. 2008 Jun 3;178(12):1563-9
references.pmid: 18519904
references.citation: Ann Emerg Med. 2011 Sep;58(3):270-279.e4
references.pmid: 21354651
references.citation: Med Care. 2007 Oct;45(10 Supl 2):S103-7
references.pmid: 17909367
references.citation: Acad Emerg Med. 2012 Jun;19(6):640-9
references.pmid: 22687179
references.citation: Ann Emerg Med. 2010 Jun;55(6):493-502.e4
references.pmid: 20005010
references.citation: Br J Clin Pharmacol. 2008 Mar;65(3):303-16
references.pmid: 18093253
references.citation: Pharmacoeconomics. 2003;21(9):623-50
references.pmid: 12807365
references.citation: Ann Emerg Med. 2001 Dec;38(6):666-71
references.pmid: 11719747
references.citation: Am J Epidemiol. 2001 Nov 1;154(9):854-64
references.pmid: 11682368
references.citation: BMC Clin Pharmacol. 2007 Sep 25;7:9
references.pmid: 17894876
references.citation: Acad Emerg Med. 2005 Mar;12(3):197-205
references.pmid: 15741581
references.citation: Ann Intern Med. 2004 May 18;140(10):795-801
references.pmid: 15148066
references.citation: JAMA. 1997 Jan 22-29;277(4):301-6
references.pmid: 9002492
references.citation: BMC Health Serv Res. 2013 Nov 12;13:473
references.pmid: 24219303
references.citation: N Engl J Med. 2011 Nov 24;365(21):2002-12
references.pmid: 22111719
references.citation: CJEM. 2002 Jan;4(1):16-22
references.pmid: 17637144